Page last updated: 2024-08-23

etoposide and Sarcoma

etoposide has been researched along with Sarcoma in 132 studies

Research

Studies (132)

Timeframe	Studies, this research(%)	All Research%
pre-1990	11 (8.33)	18.7374
1990's	47 (35.61)	18.2507
2000's	45 (34.09)	29.6817
2010's	19 (14.39)	24.3611
2020's	10 (7.58)	2.80

Authors

Authors	Studies
Kakikawa, M; Shibaki, R	1
Chan, WT; Hou, JY; Jiang, CB; Lee, HC; Liu, HC; Liu, YC; Sheu, JC; Wu, PS; Yeh, TC; Yeung, CY	1
Alva, E; Bukowinski, A; Cramer, SL; Daley, J; Escoto, H; Fair, D; Hartt, D; Kim, H; LeBlanc, Z; Merjaneh, N; Metts, J; Pressey, JG; Ray, A; Szabo, S; Todd, K; Watanbe, M	1
Ahmed, SK; Allen-Rhoades, W; Heidenreich, MJ; Houdek, MT; Petersen, IA; Robinson, SI; Rose, PS; Siontis, BL	1
Ebinger, M; Fuchs, J; Heinz, AT; Klingebiel, T; Koscielniak, E; Kratz, CP; Ljungman, G; Münter, MW; Pajtler, KW; Rößler, J; Schönstein, A; Seitz, G; Sparber-Sauer, M; Stegmaier, S; Timmermann, B; Vokuhl, C; von Kalle, T	1
Batur, A; Isik Bedir, S; Karabagli, H; Karabagli, P; Koksal, Y; Ozturk, M; Yavas, G	1
Ebinger, M; Fuchs, J; Heinz, AT; Juntti, H; Klingebiel, T; Koscielniak, E; Kratz, CP; Ljungman, G; Münter, M; Pajtler, KW; Schönstein, A; Seitz, G; Sparber-Sauer, M; Stegmaier, S; Timmermann, B; Vokuhl, C; von Kalle, T	1
Hao, J; Jing, Y; Wu, W; Xu, Q	1
Bassale, S; Davis, LE; Lim, JY; Lu, E; Ryan, CW	1
Al-Rohil, RN; Bentley, RC; Cardona, DM; Feng, X; Jour, G; Shen, G; Underwood, CIM	1
Abdel-Rahman, S; Angele, M; Belka, C; Daugaard, S; Dürr, HR; Ghadjar, P; Gronchi, A; Hiddemann, W; Hohenberger, P; Issels, RD; Jauch, KW; Knösel, T; Lindner, LH; Mansmann, U; Mella, O; Reichardt, P; Salat, C; Schmidt, M; Verweij, J; Vujaskovic, Z; Wessalowski, R; Wust, P	1
Banavali, S; Devadas, SK	1
Bartz, PJ; Collins, CL; Lal, DR; Segura, AD; Tower, RL; Woods, RK	1
Bischof, M; Debus, J; Egerer, G; Grüllich, C; Hensley, FW; Huber, PE; Kasper, B; Lehner, B; Mechtersheimer, G; Roeder, F; Schmitt, T; Sedlaczek, O; Wuchter, P	1
Barber, J; Coutermarsh-Ott, S; Feldhaeusser, B; Gogal, R; Hill, J; Lawrence, J; Saba, C; Smith, J; Turek, M	1
Blomen, V; Brummelkamp, TR; Hoogstraat, M; Janssen, L; Lips, EH; Neefjes, J; Pang, B; Qiao, X; van der Zanden, SY; Wessels, L; Wijdeven, RH	1
Bartels, U; Bouffet, E; Hader, W; Hawkins, C; Lafay-Cousin, L; Laperriere, N; Laughlin, S; Lindzon, G; Nordal, R; Taylor, MD	1
Kaneko, T; Koike, K; Kurata, T; Motobayashi, M; Nakazawa, Y; Sano, K; Shigemura, T; Sumi, T; Suzuki, S; Watanabe, T	1
Baek, SW; Choi, YS; Jo, DY; Kim, S; Lee, HJ; Moon, JY; Ryu, H; Song, IC; Yun, HJ	1
Amoroso, L; Benhamou, E; Cacchione, A; Couanet, DV; Hartmann, O; LeMaitre, A; Simonnard, N	1
Baba, S; Hosokawa, S; Mineta, H; Suzuki, K; Takebayashi, S	1
Bielack, SS; Brecht, I; Dantonello, TM; Dickerhoff, R; Gadner, H; Greiner, J; Greulich, M; Harms, D; Herbst, M; Int-Veen, C; Juergens, H; Kirsch, S; Klingebiel, T; Koscielniak, E; Leuschner, I; Marky, I; Scheel-Walter, HG; Schmelzle, R; Schmidt, BF; Treuner, J	1
Abdel-Rahman, S; Issels, RD; Lindner, LH; Reiser, MF; Santl, M; Stahl, R; Wang, T	1
Egerer, G; Ho, AD; Kasper, B; Schmitt, T; Wuchter, P	1
Anderson, JR; Huh, WW; Raney, RB; Rodeberg, D; Teot, L; Yock, T	1
Bui, B; Coindre, JM; Garbay, D; Italiano, A; Kantor, G; Kind, M; Lortal, B; Stoeckle, E; Toulmonde, M	1
Arnold, D; Behlendorf, T; Jordan, K; Kegel, T; Mueller, LP; Schmoll, HJ; Sippel, C; Voigt, W; Wolf, HH	1
Dimitrakopoulou-Strauss, A; Egerer, G; Haberkorn, U; Kasper, B; Lehner, B; Mechtersheimer, G; Schmitt, T; Strauss, LG; Stroebel, P; Vasamiliette, J	1
Abdel-Rahman, S; Baur-Melnyk, A; Blay, JY; Daugaard, S; Dürr, HR; Hiddemann, W; Hohenberger, P; Issels, RD; Jauch, KW; Lindner, LH; Mansmann, U; Ploner, F; Reichardt, P; Salat, C; Schem, BC; Verweij, J; Vujaskovic, Z; Wendtner, CM; Wessalowski, R; Wust, P	1
Chae, M; Kang, HS; Kim, HS; Kim, JH; Kim, WK; Kim, YJ; Yoon, S	1
Bay, JO; Blay, JY; Bonichon, F; Bui-Nguyen, B; Chevreau, C; Coindre, JM; Cupissol, D; Italiano, A; Jimenez, M; Lotz, JP; Mathoulin-Pélissier, S; Penel, N; Ray-Coquard, I; Thyss, A	1
Bischof, M; Dietrich, S; Dimitrakopoulou-Strauss, A; Egerer, G; Ho, AD; Kasper, B; Lehner, B; Mechtersheimer, G; Roeder, F; Schmitt, T; Strauss, LG; Wuchter, P	1
Chan, AW; Cianchetti, M; Deschler, DG; Liebsch, NJ; Varvares, MA; Wang, JJ	1
Bergeron, C; Bouvet, N; Ellershaw, C; Jenney, ME; Kelsey, A; Martelli, H; Merks, JH; Oberlin, O; Rey, A; Sanchez de Toledo, J; Scopinaro, M; Spooner, D; Stevens, MC	1
Abdel-Rahman, S; Baumert, J; Baur, A; Hiddemann, W; Issels, RD; Krych, M; Lindner, LH; Wendtner, CM	1
Berland, B; Cohen, C; Le Tortorec, S; Potier, P; Pozzo, A; Saint-Marc, O	1
Douglas, J; Felgenhauer, J; Gooley, T; Hawkins, DS; Kreissman, S; Park, J; Pendergrass, TW; Rowley, SD; Sanders, JE; Thomson, B	1
Dickman, PS; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Moore, S; Perlman, EJ; Pritchard, DJ; Rausen, AR; Tarbell, NJ; Vietti, TJ	1
Starkhammar, H; Wall, N	1
Bailey, H; Bakhshandeh, A; Finet, J; Gillis, W; Jager, D; Jager, E; Katschinski, DM; Knuth, A; Longo, W; Neumann, A; Peters, SO; Robins, HI; Tiggelaar, CL; Van Dijk, JD; Vörde Sive Vörding, PZ; Westermann, AM; Wiedemann, GJ	1
Hitchcock, RJ; Mitchell, CD; Patel, Y	1
Ayan, I; Görgün, O; Kebudi, R	1
Choi, SH; Hong, SY; Hyung, WJ; Jung, HC; Kim, KS; Lee, MH; Noh, SH; Roh, JK	1
Abdel-Rahman, S; Fahn, W; Fiegl, M; Issels, RD; Schlemmer, M; Wendtner, CM	1
Chuman, H	1
Anderson, B; Angiolillo, A; Cairo, MS; Cheung, YK; Davenport, V; Krailo, M; Reaman, G; Van Winkle, P	1
Abadie-Lacourtoisie, S; Catala, L; Descamps, P; Lortholary, A; Morand, C; Paillocher, N; Verriele, V	1
Oberlin, O; Orbach, D; Quintana, E; Rey, A; Sanchez de Toledo, J; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A	1
Boddy, AV; Errington, J; Lowis, S; Thomas, HD; Veal, GJ	1
Billups, CA; Cain, AM; Furman, WL; Hale, GA; Merchant, TE; Navid, F; Pappo, AS; Rao, BN; Santana, VM; Spunt, SL	1
Frater, JL; Gardner, LJ; Grosso, LE; Hurley, MY; Kling, CW; Obadiah, JM; Resh, B	1
Budach, V; Felix, R; Ganter, H; Gellermann, J; Hildebrandt, B; Issels, R; Reichardt, P; Tunn, PU; Wlodarczyk, W; Wust, P	1
Admirand, JH; Bueso-Ramos, CE; Ford, RJ; Jiang, L; Moran, C	1
Abdel-Rahman, S; Baumert, J; Falk, M; Hentrich, M; Hiddemann, W; Issels, RD; Licht, T; Salat, C; Schlemmer, M; Straka, C; Wendtner, CM	1
Bamias, A; Bozas, G; Dimopoulos, MA; Gika, D; Kastritis, E; Markaki, S; Papadimitriou, CA; Rodolakis, A; Voulgaris, Z; Zorzou, MP	1
Abidi, MH; Ibrahim, RB; Maria, D; Peres, E; Tove, I	1
Beske, F; Boos, J; Dantonello, T; Gadner, H; Hallmen, E; Int-Veen, C; Kazanowska, B; Klingebiel, T; Koscielniak, E; Marky, I; Treuner, J	1
Dietrich, S; Dimitrakopoulou-Strauss, A; Egerer, G; Haberkorn, U; Ho, AD; Kasper, B; Strauss, LG	1
Cheerva, AC; Gross, TG; Kadota, RP; Levine, JE; Ozkaynak, MF; Richards, MK; Rozans, MK; Sahdev, I; Shaw, PJ	1
Jungi, WF	1
Dimitriadis, K; Schmidt, CG; Schütte, J; Seeber, S	1
Saeter, G; Solheim, OP; Talle, K	1
Ayash, LJ; Elias, AD; Frei, E; Gonin, R; Mazanet, R; McCauley, M; Schnipper, L; Schwartz, G; Tepler, I; Wheeler, C	1
Cairo, MS	1
Asbury, RF; Boros, L; Chang, AY; Garrow, GC	1
Balis, FM; Bates, SE; Bryant, G; Chabner, BA; Jamis-Dow, C; Klecker, RW; Kohler, DR; Steinberg, SM; Wilson, WH; Wittes, RE	1
Flamant, F; Phillips, MB; Pinkerton, CR; Sommelet-Olive, D	1
Ahn, DC; Doroshow, JH; Forman, SJ; Hwang, L; Leong, LA; Lev-Ran, A; Margolin, KA; Morgan, RJ; Raschko, JW; Somlo, G	1
Ballester, OF; Cooper, BW; Creger, RJ; Elfenbein, GJ; Fields, KK; Hiemenz, JH; Janssen, WE; Lazarus, HM; Perkins, JB; Zorsky, PE	1
Baker, LH; Blair, SC; Zalupski, MM	1
Adler, SS; Feingold, JM; Ghalie, R; Kaizer, H; Korenblit, AD; Manson, S; Pruett, J; Reynolds, J; Valentino, LA	1
Chen, KG; Durán, GE; Jaffrézou, JP; Kühl, JS; Sikic, BI	1
Goodin, S; Gosland, M; Hoffman, T; Tsuboi, C; Vore, M	1
Davidson, A; Lewis, I; Pearson, AD; Pinkerton, CR; Stevens, MC	1
Antman, KH; Gonin, R; Licht, JD; Loehrer, PJ; Mazanet, R	1
Hamdan, H; Skubitz, KM; Thompson, RC	1
Craft, AW; Pearson, AD; Yule, SM	1
Bouffet, E; Bouhour, D; Brunat-Mentigny, M; Carrie, C; Frappaz, D; Grabois, M; Philip, T	1
Hibi, S; Imashuku, S; Kataoka, Y; Morimoto, M; Naya, M; Takaya, K; Todo, S	1
Aherne, GW; Dick, G; Pinkerton, CR	1
Cole, M; Lowis, SP; Newell, DR; Pearson, AD	1
Bell, DR; Dalley, D; Levi, J; Simes, RJ; Stuart-Harris, R; Wiltshaw, E	1
Kellner, R; Schütte, J; Seeber, S	1
Abdel-Rahman, S; Berger, H; Bosse, D; Issels, RD; Jauch, KW; Panzer, M; Peter, K; Sauer, H; Starck, M; Stiegler, H	1
Baker, LH; Zalupski, MM	1
Aziz, SM; Crooks, PA; Gillespie, MN; Gosland, MP; Olson, JW; Tofiq, S; Tsuboi, CP	1
Asbury, RF; Boros, L; Chang, AY; Garrow, GC; Hui, L	1
Crahé, R; Deeken, M; Eleftheriadis, S; Gutsche, S; Katschinski, DM; Mentzel, M; Robins, HI; Storer, B; Wagner, T; Weiss, C; Wiedemann, GJ	1
Katschinski, DM; Mentzel, M; Mulkerin, DL; Robins, HI; Touhidi, R; Wiedemann, GJ	1
Colvin, OM	1
Verweij, J	1
Alvegård, TA; Erlanson, M; Hannisdal, E; Klepp, R; Monge, OR; Raabe, N; Saeter, G; Söderberg, M; Solheim, OP; Strander, H; Turesson, I; Wist, E	1
Chan, HS; Doyle, J; Greenberg, ML; Karaskov, V; Koren, G; Malkin, D; Moncica, I; Theis, JG	2
Hess, CF; Jürgens, H; Klingebiel, T; Koscielniak, E; Pertl, U; Pötter, R; Rossi, R; Schött, C; Spaar, HJ; Treuner, J; van Heek-Romanowski, R; Willnow, U	1
Barişta, I; Celik, I; Güllü, I; Kars, A; Ozişik, Y; Tekuzman, G; Yalçin, S	1
Budman, DR; Calabro, A; Kreis, W	1
Arndt, CA; Miser, JS; Moertel, CL; Nascimento, AG; Neglia, JP; Schomberg, PJ; Schroeder, G; Sencer, SF; Silberman, TL; Tillisch, JK	1
Yalçin, S	2
Alvegård, TA; Fernberg, JO; Hall, KS; Monge, O; Saeter, G; Strander, H; Wiklund, T	1
Conrad, EU; Felgenhauer, J; Hawkins, D; Lindsley, K; Miser, JS; Pendergrass, T	1
Daller, RT; Fenton, JG; Miser, JS; Womer, RB	1
Filejski, W; Gerke, P; Robins, HI; Steinhoff, J; Wiedemann, GJ	1
Hamana, T; Miyagi, N; Takahashi, M	1
Bash, RO; Herrera, L; Kamen, BA; Leavey, PJ; Mantadakis, E; Winick, NJ	1
Bodoky, G; Eckhardt, S; Láng, I; Pápai, Z; Poller, I; Rahóty, P; Szántó, J; Szendroi, M	1
Beketic-Oreskovic, L; Chen, GK; Durán, GE; Mangili, A; Sikic, BI	1
Barriga, F; García, C; González, S; Holmgren, NL; Méndez, M; Sánchez, I	1
Biron, P; Blay, JY; Bouhour, D; Dumontet, C; Philip, T; Ray-Coquard, I	1
Abdel-Rahman, S; Aydemir, U; Falk, MH; Hiddemann, W; Issels, RD; Kurze, V; Sauer, H; Wendtner, C	1
Abdel-Rahman, S; Baumert, J; Falk, MH; Hiddemann, W; Issels, RD; Krych, M; Santl, M; Wendtner, C	1
Bertino, JR; Cordon-Cardo, C; Elisseyeff, Y; Faircloth, G; Jhanwar, S; Jimeno, J; Li, WW; Takahashi, N	1
Bai, P; Sun, J; Zhang, W	1
Anderson, JR; Barr, FG; Crist, WM; Donaldson, SS; Maurer, HM; Pappo, AS; Qualman, SJ; Raney, RB; Wiener, ES	1
Arnold, AM	1
Fujita, J; Fujita, T; Irino, S; Kubo, A; Morikawa, N; Shiotani, T; Takahara, J; Takigawa, K; Yamagishi, Y; Yamaji, Y	1
Foster, J; Kampe, CE; Lowenbraun, S; Rosen, G	1
Biron, P; Blay, JY; Bouffet, E; Brunat-Mentigny, M; Chauvin, F; Clavel, M; Dumontet, C; Meckenstock, R; Philip, I; Philip, T	1
Phillips, MB; Pinkerton, CR	1
Gonzalez-Vela, JL; Kennedy, BJ; Manivel, JC; Savage, PD; Torkelson, JL	1
Denzlinger, C; Gerl, A; Issels, RD; Mittermüller, J; Ortmaier, A; Sauer, H; Simon, W; Wilmanns, W	1
Berger, H; Boehm, E; Denecke, H; Issels, RD; Jauch, KW; Nagele, A; Peter, K; Prenninger, SW; Sauer, H; Wilmanns, W	1
Iqbal, Z; Mallick, JA; Zaidi, SH	1
Raffin, TA; Sikic, BI; Yamauchi, T; Yang, P	1
Buckner, JC; Edmonson, JH; Long, HJ; Loprinzi, CL; Schaid, DJ	1
Ajani, JA; Baker, FL; Blaauw, AA; Dicke, KA; Spitzer, G; Thielvoldt, D; Tomasovic, B; Umbach, G; Zander, AR	1
Gosland, MP; Lum, BL; Sikic, BI	1
Forquer, R; Jarosinski, P; Kinsella, TJ; Magrath, I; Miser, JS; Triche, TJ; Tsokos, M; Wesley, R	1
Calculli, G; Carli, M; Ceci, A; De Bernardi, B; di Montezemolo, LC; Di Tullio, MT; Grotto, P; Paolucci, G; Perilongo, G; Pianca, C	1
Bramwell, V; Buesa, J; Dombernowsky, P; Mouridsen, H; Onsrud, M; Pinedo, HM; Rouesse, J; Santoro, A; Somers, R; Thomas, D	1
Raney, RB	1

Reviews

7 review(s) available for etoposide and Sarcoma

Article	Year
[Current strategy of chemotherapy for reflactory bone and soft tissue sarcomas]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Carboplatin; Cisplatin; Clinical Trials, Phase II as Topic; Docetaxel; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Imatinib Mesylate; Lung Neoplasms; Piperazines; Prognosis; Pyrimidines; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Taxoids	2004
[Low-grade endometrial stromal sarcoma: contribution of hormone therapy and etoposide]. Journal de gynecologie, obstetrique et biologie de la reproduction, 2005, Volume: 34, Issue:1 Pt 1 Topics: Antineoplastic Agents, Phytogenic; Endometrial Neoplasms; Etoposide; Female; Humans; Middle Aged; Pregnancy; Progestins; Sarcoma	2005
The use of ifosfamide, carboplatin, and etoposide in children with solid tumors. Seminars in oncology, 1995, Volume: 22, Issue:3 Suppl 7 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Neoplasms; Neuroblastoma; Neutropenia; Sarcoma; Thrombocytopenia; Wilms Tumor	1995
Drug resistance in the treatment of sarcomas. Seminars in oncology, 1997, Volume: 24, Issue:5 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Paclitaxel; Platinum Compounds; Sarcoma	1997
Chemotherapy in soft tissue sarcoma. The Scandinavian Sarcoma Group experience. Acta orthopaedica Scandinavica. Supplementum, 1999, Volume: 285 Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Prognosis; Registries; Remission Induction; Risk Factors; Sarcoma; Scandinavian and Nordic Countries; Soft Tissue Neoplasms; Treatment Outcome	1999
Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Male; Melphalan; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Rhabdomyosarcoma; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Topotecan; Treatment Outcome; Vincristine	2001
Podophyllotoxin derivative VP 16-213. Cancer chemotherapy and pharmacology, 1979, Volume: 3, Issue:2 Topics: Animals; Bronchial Neoplasms; Carcinoma; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; In Vitro Techniques; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Lymphoma; Mice; Neoplasms; Podophyllotoxin; Rabbits; Rats; Sarcoma	1979

Trials

49 trial(s) available for etoposide and Sarcoma

Article	Year
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial. JAMA oncology, 2018, Apr-01, Volume: 4, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Progression-Free Survival; Risk Factors; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome; Young Adult	2018
Retrospective Analysis of Outcomes of Patients with Relapsed, Refractory and Metastatic Sarcomas who have received Metronomic Chemotherapy. The Gulf journal of oncology, 2019, Volume: 1, Issue:30 Topics: Administration, Metronomic; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rhabdomyosarcoma; Salvage Therapy; Sarcoma; Sarcoma, Ewing; Survival Rate; Tamoxifen; Young Adult	2019
Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial. BMC cancer, 2014, May-20, Volume: 14 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Etoposide; Female; Germany; Humans; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Sarcoma; Soft Tissue Neoplasms; Time Factors; Treatment Outcome; Young Adult	2014
Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Mar-20, Volume: 27, Issue:9 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Soft Tissue Neoplasms; Vincristine; Young Adult	2009
Comparison of radiological and pathohistological response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) and study of response dependence on the applied thermal parameters in patients with soft tissue sarcomas (STS). International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2009, Volume: 25, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Sarcoma; Soft Tissue Neoplasms; Thermography; Treatment Outcome	2009
"Metronomic" chemotherapy in advanced soft tissue sarcomas. Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Sarcoma; Treatment Outcome	2010
Impact of dynamic 18F-FDG PET on the early prediction of therapy outcome in patients with high-risk soft-tissue sarcomas after neoadjuvant chemotherapy: a feasibility study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Volume: 51, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Discriminant Analysis; Doxorubicin; Etoposide; Feasibility Studies; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ifosfamide; Neoadjuvant Therapy; Patient Selection; Radionuclide Imaging; Risk; Sarcoma; Time Factors; Treatment Outcome	2010
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. The Lancet. Oncology, 2010, Volume: 11, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Retroperitoneal Neoplasms; Sarcoma; Survival Rate; Young Adult	2010
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Consolidation Chemotherapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Mesna; Middle Aged; Peripheral Blood Stem Cell Transplantation; Sarcoma; Young Adult	2012
A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma. BMC cancer, 2011, Dec-07, Volume: 11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Sarcoma; Soft Tissue Neoplasms; Young Adult	2011
Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatr Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Jul-10, Volume: 30, Issue:20 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Male; Prognosis; Rhabdomyosarcoma; Sarcoma; Treatment Outcome; Vincristine	2012
Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jul-15, Volume: 20, Issue:14 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Prospective Studies; Radiography; Retroperitoneal Neoplasms; Sarcoma; Survival Analysis; Treatment Outcome; Viscera	2002
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. The New England journal of medicine, 2003, Feb-20, Volume: 348, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Prognosis; Sarcoma; Sarcoma, Ewing; Survival Rate; Treatment Failure; Vincristine	2003
A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma. Oncology, 2003, Volume: 64, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Hyperthermia, Induced; Ifosfamide; Lenograstim; Male; Middle Aged; Recombinant Proteins; Sarcoma; Survival Analysis; Treatment Outcome	2003
Oral etoposide for recurrent/progressive sarcomas of childhood. Pediatric blood & cancer, 2004, Volume: 42, Issue:4 Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Disease Progression; Etoposide; Female; Humans; Male; Neoplasms, Second Primary; Palliative Care; Recurrence; Remission Induction; Sarcoma; Survival Rate; Treatment Outcome	2004
Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2004, Volume: 20, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Hyperthermia, Induced; Ifosfamide; Leukopenia; Male; Middle Aged; Neoplasm Staging; Patient Selection; Salvage Therapy; Sarcoma; Survival Rate; Thrombocytopenia; Treatment Outcome	2004
Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience. Pediatric blood & cancer, 2005, Volume: 44, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Colony-Stimulating Factors; Etoposide; Female; Humans; Ifosfamide; Male; Multivariate Analysis; Proportional Hazards Models; Recurrence; Rhabdomyosarcoma; Sarcoma; Survival Rate	2005
Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jul-01, Volume: 23, Issue:19 Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Infant, Newborn; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rhabdomyosarcoma; Sarcoma; Survival Analysis; Teniposide; Vincristine	2005
Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience. Cancer, 2006, Apr-15, Volume: 106, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Vincristine	2006
Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry. Cancer, 2006, Sep-15, Volume: 107, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Body Temperature; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Hyperthermia, Induced; Ifosfamide; Magnetic Resonance Imaging; Monitoring, Physiologic; Reproducibility of Results; Sarcoma; Thermography; Treatment Outcome	2006
Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas. Oncology, 2006, Volume: 71, Issue:1-2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Transplantation, Autologous	2006
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial. Pediatric blood & cancer, 2008, Volume: 50, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Melphalan; Sarcoma; Soft Tissue Neoplasms; Thiotepa; Treatment Outcome; Vincristine	2008
Early prediction of therapy outcome in patients with high-risk soft tissue sarcoma using positron emission tomography. Onkologie, 2008, Volume: 31, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sarcoma; Sensitivity and Specificity; Treatment Outcome	2008
A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors-A pediatric blood and marrow transplant consortium study. Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:3 Topics: Adolescent; Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Etoposide; Feasibility Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Hypocalcemia; Kidney Neoplasms; Melphalan; Neoplasms; Neuroblastoma; Pilot Projects; Recurrence; Risk Factors; Sarcoma; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Wilms Tumor	2008
Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support. Bone marrow transplantation, 1995, Volume: 15, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Digestive System; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Nervous System; Ovarian Neoplasms; Sarcoma; Survival Rate; Testicular Neoplasms; Transplantation, Autologous	1995
Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide. Seminars in oncology, 1995, Volume: 22, Issue:3 Suppl 7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Adenoid Cystic; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Remission Induction; Sarcoma	1995
Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Cyclophosphamide; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Hypotension; Leukocyte Count; Lymphoma; Male; Middle Aged; Neutrophils; Platelet Count; Prednisone; Sarcoma; Stereoisomerism; Verapamil; Vincristine	1995
Phase II study of rapid-scheduled etoposide in paediatric soft tissue sarcomas. European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:5 Topics: Adolescent; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Infusions, Intravenous; Male; Neoplasm, Residual; Rhabdomyosarcoma; Sarcoma	1995
Effect of low-dose prophylactic dopamine on high-dose cisplatin-induced electrolyte wasting, ototoxicity, and epidermal growth factor excretion: a randomized, placebo-controlled, double-blind trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Creatinine; Cyclophosphamide; Dopamine; Double-Blind Method; Electrolytes; Epidermal Growth Factor; Etoposide; Female; Hearing Loss; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Sarcoma; Soft Tissue Neoplasms; Water-Electrolyte Imbalance	1995
Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:2 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Drug Tolerance; Etoposide; Female; Germinoma; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Ovarian Neoplasms; Prognosis; Sarcoma; Testicular Neoplasms; Transplantation, Autologous	1995
Ifosfamide and etoposide in the treatment of advanced soft tissue sarcomas. American journal of clinical oncology, 1994, Volume: 17, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Ifosfamide; Leiomyosarcoma; Male; Middle Aged; Sarcoma; Survival Analysis	1994
Phase IV trial of daily oral etoposide in the treatment of advanced soft-tissue sarcoma. Cancer chemotherapy and pharmacology, 1994, Volume: 34, Issue:1 Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Sarcoma	1994
Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas. Cancer, 1993, Nov-15, Volume: 72, Issue:10 Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Infusion Pumps; Infusions, Intravenous; Male; Mesna; Middle Aged; Remission Induction; Sarcoma; Soft Tissue Neoplasms	1993
Low-dose, continuous infusion 5-fluorouracil and oral etoposide for the treatment of advanced sarcomas. The Journal of infusional chemotherapy, 1995,Summer, Volume: 5, Issue:3 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Sarcoma; Stomatitis; Treatment Outcome	1995
Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 degrees C whole body hyperthermia in patients with refractory sarcoma. European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Pilot Projects; Sarcoma	1996
Optimization of chemotherapy administration for clinical 41.8 degrees C whole body hyperthermia. Cancer letters, 1997, May-19, Volume: 115, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Body Temperature; Breast Neoplasms; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Cross-Over Studies; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Hyperthermia, Induced; Ifosfamide; Lung Neoplasms; Male; Neutropenia; Platelet Count; Sarcoma	1997
Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group Phase II Study. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:10 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Recombinant Proteins; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Treatment Outcome	1997
Increased systemic toxicity of sarcoma chemotherapy due to combination with the P-glycoprotein inhibitor cyclosporin. International journal of clinical pharmacology and therapeutics, 1998, Volume: 36, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Cyclophosphamide; Cyclosporine; Dactinomycin; Drug Interactions; Etoposide; Fever; Humans; Ifosfamide; Immunosuppressive Agents; Neutropenia; Patient Admission; Retrospective Studies; Sarcoma; Sepsis; Soft Tissue Neoplasms; Vincristine	1998
Treatment of advanced refractory sarcomas with ifosfamide and etoposide combination chemotherapy. Cancer investigation, 1998, Volume: 16, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Sarcoma	1998
Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas. Medical and pediatric oncology, 2000, Volume: 34, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Child; Child, Preschool; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Mesna; Mouth Mucosa; Neoplasm Metastasis; Neutropenia; Prospective Studies; Remission Induction; Sarcoma; Stomatitis; Time Factors; Treatment Outcome; Vincristine	2000
[Effectiveness of carboplatin and etoposide selective intra-arterial chemotherapy for progressive soft-tissue sarcoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intra-Arterial; Middle Aged; Sarcoma; Soft Tissue Neoplasms	2000
Fractionated cyclophosphamide and etoposide for children with advanced or refractory solid tumors: a phase II window study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:13 Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Male; Neoplasms; Sarcoma	2000
The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma. Cancer, 2000, Jul-01, Volume: 89, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome	2000
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Nov-01, Volume: 18, Issue:21 Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Graft Rejection; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Pilot Projects; Prospective Studies; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Survival Analysis	2000
Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study. European journal of cancer (Oxford, England : 1990), 2001, Volume: 37, Issue:13 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Risk Factors; Sarcoma; Treatment Outcome	2001
Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia. European journal of cancer (Oxford, England : 1990), 2001, Volume: 37, Issue:13 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; Sarcoma; Treatment Outcome	2001
[Combination chemotherapy of uterine sarcomas]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2000, Volume: 22, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Mitolactol; Mitomycins; Neoplasm Recurrence, Local; Postoperative Period; Retrospective Studies; Sarcoma; Survival Rate; Uterine Neoplasms	2000
Podophyllotoxin derivative VP 16-213. Cancer chemotherapy and pharmacology, 1979, Volume: 3, Issue:2 Topics: Animals; Bronchial Neoplasms; Carcinoma; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; In Vitro Techniques; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Lymphoma; Mice; Neoplasms; Podophyllotoxin; Rabbits; Rats; Sarcoma	1979
Ifosfamide in soft tissue sarcoma. JPMA. The Journal of the Pakistan Medical Association, 1990, Volume: 40, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Mesna; Sarcoma; Soft Tissue Neoplasms	1990

Other Studies

77 other study(ies) available for etoposide and Sarcoma

Article	Year
Different effects of magnetic field on drug activity in human uterine sarcoma cell lines MES-SA and MES-SA/Dx5. Electromagnetic biology and medicine, 2022, Jul-03, Volume: 41, Issue:3 Topics: Antineoplastic Agents; Cell Line; Cell Line, Tumor; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Magnetic Fields; Sarcoma; Uterine Neoplasms	2022
Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report. Medicine, 2022, Nov-25, Volume: 101, Issue:47 Topics: Adolescent; Cyclophosphamide; Dysuria; Epirubicin; Etoposide; Flank Pain; Humans; Ifosfamide; Male; Pancreas; Pancreatic Neoplasms; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine	2022
Strategies for the Treatment of Infantile Soft Tissue Sarcomas With BCOR Alterations. Journal of pediatric hematology/oncology, 2023, 08-01, Volume: 45, Issue:6 Topics: Biomarkers, Tumor; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Neoplasm Recurrence, Local; Proto-Oncogene Proteins; Repressor Proteins; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Vincristine	2023
Treatment outcomes of extraskeletal Ewing sarcoma. Journal of surgical oncology, 2023, Volume: 128, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Male; Sarcoma; Sarcoma, Ewing; Treatment Outcome; Vincristine	2023
Second-line treatment of pediatric patients with relapsed rhabdomyosarcoma adapted to initial risk stratification: Data of the European Soft Tissue Sarcoma Registry (SoTiSaR). Pediatric blood & cancer, 2023, Volume: 70, Issue:7 Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Chronic Disease; Cyclophosphamide; Etoposide; Humans; Polyketides; Recurrence; Retrospective Studies; Rhabdomyosarcoma; Sarcoma; Soft Tissue Neoplasms; Topotecan	2023
Radiation-induced Desmoid Tumor Development in the Radiotherapy Field in a Child With Pineoblastoma: A Case Report. Journal of pediatric hematology/oncology, 2023, Jul-01, Volume: 45, Issue:5 Topics: Brain Neoplasms; Child; Etoposide; Female; Fibromatosis, Aggressive; Humans; Pineal Gland; Pinealoma; Sarcoma	2023
Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR. Pediatric blood & cancer, 2024, Volume: 71, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Etoposide; Humans; Registries; Rhabdomyosarcoma; Rhabdomyosarcoma, Alveolar; Risk Factors; Sarcoma; Soft Tissue Neoplasms	2024
Therapy-related acute myeloid leukemia secondary to histiocytic sarcoma. Minerva medica, 2021, Volume: 112, Issue:5 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Neoplasms, Second Primary; Polyethylene Glycols; Prednisone; Sarcoma; Vincristine	2021
Feasibility of Treating Adults with Ewing or Ewing-Like Sarcoma with Interval-Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide. The oncologist, 2020, Volume: 25, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Humans; Ifosfamide; Middle Aged; Retrospective Studies; Sarcoma; Vincristine; Young Adult	2020
Epithelioid Hyalinizing Sarcoma With MGA-NUTM1 Fusion. American journal of clinical pathology, 2020, 11-04, Volume: 154, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Basic Helix-Loop-Helix Transcription Factors; Cyclophosphamide; Dactinomycin; Etoposide; Foot; Foot Bones; Gene Fusion; Humans; Hyalin; Ifosfamide; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Nuclear Proteins; Organophosphorus Compounds; Sarcoma; Vincristine	2020
Significant response to oral Etoposide in the treatment of an unresectable cardiac sarcoma. Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:4 Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Biopsy; Child; Etoposide; Female; Heart Neoplasms; Humans; Remission Induction; Sarcoma	2014
In vitro efficacy of doxorubicin and etoposide against a feline injection site sarcoma cell line. Research in veterinary science, 2014, Volume: 97, Issue:2 Topics: Animals; Antineoplastic Agents; Apoptosis; Cat Diseases; Cats; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Drug Therapy, Combination; Etoposide; In Vitro Techniques; Neoplasms, Connective Tissue; Sarcoma	2014
Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in Cancer. Cancer research, 2015, Oct-01, Volume: 75, Issue:19 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis Regulatory Proteins; Capecitabine; Carcinoma; Chromosomal Proteins, Non-Histone; CRISPR-Cas Systems; Cyclophosphamide; DNA Helicases; DNA-Binding Proteins; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Profiling; Genome-Wide Association Study; Humans; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Neoplasm Proteins; Nuclear Proteins; RNA Interference; RNA, Small Interfering; Sarcoma; SMARCB1 Protein; Taxoids; Topoisomerase II Inhibitors; Topotecan; Transcription Factors; Triple Negative Breast Neoplasms	2015
Successful treatment of primary intracranial sarcoma with the ICE chemotherapy regimen and focal radiation in children. Journal of neurosurgery. Pediatrics, 2016, Volume: 17, Issue:3 Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Canada; Carboplatin; Cerebrum; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Intracranial Hemorrhages; Male; Neurofibromatoses; Retrospective Studies; Sarcoma; Treatment Outcome	2016
Dramatic Reduction in Tumor Size During 5 Months of Pazopanib Therapy in Combination With Ifosfamide, Carboplatin, and Etoposide in an Early Infant With Progressive Soft Tissue Sarcoma. Journal of pediatric hematology/oncology, 2017, Volume: 39, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Indazoles; Infant; Male; Pyrimidines; Remission Induction; Sarcoma; Sulfonamides	2017
VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma. Medicine, 2017, Volume: 96, Issue:4 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Podophyllotoxin; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Young Adult	2017
Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen. Bone marrow transplantation, 2008, Volume: 42, Issue:7 Topics: Adolescent; Antineoplastic Agents; Brain Neoplasms; Busulfan; Carboplatin; Child; Child, Preschool; Clonazepam; Etoposide; Female; Hepatic Veno-Occlusive Disease; Humans; Infant; Male; Retrospective Studies; Risk Factors; Sarcoma; Seizures; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Young Adult	2008
Undifferentiated sarcoma of the maxillary sinus: report of a rare case in an adult. Auris, nasus, larynx, 2009, Volume: 36, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Male; Maxillary Sinus Neoplasms; Mesna; Middle Aged; Protective Agents; Sarcoma; Vincristine	2009
[Positron emission tomography as a tool for early prediction of therapy outcome in soft tissue sarcoma]. Deutsche medizinische Wochenschrift (1946), 2009, Volume: 134, Issue:39 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Young Adult	2009
Orbital sarcoma with metastases at diagnosis: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatric blood & cancer, 2010, Jul-01, Volume: 54, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Orbital Neoplasms; Radiotherapy; Sarcoma; Treatment Outcome; Vincristine	2010
Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a feasibility study. Bone marrow transplantation, 2010, Volume: 45, Issue:12 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Sarcoma; Young Adult	2010
Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein. British journal of pharmacology, 2011, Volume: 162, Issue:3 Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Comet Assay; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hep G2 Cells; Humans; In Situ Nick-End Labeling; Proteasome Endopeptidase Complex; Pyrans; Sarcoma; Uterine Neoplasms	2011
Risk of sinonasal-cutaneous fistula after treatment for advanced sinonasal cancer. Journal of surgical oncology, 2012, Volume: 105, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Cutaneous Fistula; Etoposide; Female; Fistula; Follow-Up Studies; Humans; Male; Middle Aged; Nasal Cavity; Neuroectodermal Tumors; Paranasal Sinus Diseases; Paranasal Sinus Neoplasms; Paranasal Sinuses; Postoperative Complications; Radiotherapy; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Sarcoma; Young Adult	2012
[Gastric interdigitating reticulum cell sarcoma: unusual presentation of a histiocytic tumor]. Gastroenterologie clinique et biologique, 2002, Volume: 26, Issue:5 Topics: Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Cytarabine; Diagnosis, Differential; Etoposide; Gastrectomy; Histiocytes; Humans; Immunohistochemistry; Male; Methylprednisolone; Middle Aged; Sarcoma; Stomach Neoplasms	2002
Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas. Cancer, 2002, Sep-15, Volume: 95, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Male; Mesna; Neoplasm Metastasis; Remission Induction; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Treatment Outcome; Vincristine	2002
Chemotherapy of soft tissue sarcoma--a clinical evaluation of treatment over ten years. Acta oncologica (Stockholm, Sweden), 2003, Volume: 42, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Gallium; Humans; Ifosfamide; Male; Middle Aged; Palliative Care; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Vinblastine; Vincristine	2003
Use of sarcoma-based chemotherapy in a case of congenital mesoblastic nephroma with liver metastases. Urology, 2003, Volume: 61, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Kidney Neoplasms; Liver Neoplasms; Nephroma, Mesoblastic; Sarcoma; Vincristine	2003
Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse model. World journal of gastroenterology, 2004, Apr-15, Volume: 10, Issue:8 Topics: Adenoviridae; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Hepatocellular; Cell Line, Tumor; Combined Modality Therapy; Drug Synergism; Endostatins; Endothelium, Vascular; Enzyme Inhibitors; Etoposide; Gene Expression; Genetic Therapy; Humans; Liver Neoplasms; Mice; Sarcoma; Survival Rate; Topoisomerase Inhibitors; Umbilical Veins	2004
Biliary excretion of etoposide in children with cancer. Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:3 Topics: Adolescent; Antineoplastic Agents, Phytogenic; Bile; Child, Preschool; Drainage; Etoposide; Female; Humans; Male; Metabolic Clearance Rate; Sarcoma	2006
Histiocytic sarcoma with secondary involvement of the skin and expression of CD1a: evidence of indeterminate cell differentiation? Journal of cutaneous pathology, 2006, Volume: 33, Issue:6 Topics: Antigens, CD1; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cell Proliferation; Cell Transformation, Neoplastic; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Etoposide; Histiocytes; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Sarcoma; Skin Neoplasms; Tonsillar Neoplasms; Vincristine	2006
Mediastinal follicular dendritic cell sarcoma involving bone marrow: a case report and review of the literature. Annals of diagnostic pathology, 2006, Volume: 10, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Dendritic Cells, Follicular; Deoxycytidine; Docetaxel; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Immunoenzyme Techniques; Mediastinal Neoplasms; Methotrexate; Middle Aged; Sarcoma; Taxoids; Treatment Outcome	2006
Anthracycline-based adjuvant chemotherapy in early-stage uterine sarcomas: long-term results of a single institution experience. European journal of gynaecological oncology, 2007, Volume: 28, Issue:2 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Staging; Sarcoma; Survival Analysis; Treatment Outcome; Uterine Neoplasms	2007
Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant. American journal of hematology, 2007, Volume: 82, Issue:10 Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Histiocytes; Humans; Middle Aged; Prednisone; Retroperitoneal Neoplasms; Sarcoma; Thalidomide; Vincristine	2007
Etoposide single-agent chemotherapy for solid tumors. Cancer treatment reviews, 1982, Volume: 9 Suppl Topics: Carcinoma, Hepatocellular; Etoposide; Female; Head and Neck Neoplasms; Humans; Liver Neoplasms; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Sarcoma; Soft Tissue Neoplasms	1982
Experimental basis and clinical experience with non-cross-resistant combinations in solid tumours. Cancer treatment reviews, 1984, Volume: 11 Suppl A Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Ehrlich Tumor; Carcinoma, Small Cell; Cell Line; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Humans; Ifosfamide; Male; Naphthacenes; Sarcoma; Teratoma; Testicular Neoplasms; Vinca Alkaloids; Vincristine	1984
Treatment of advanced, high-grade soft-tissue sarcoma with ifosfamide and continuous-infusion etoposide. Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Leukopenia; Neoplasm Staging; Neutropenia; Sarcoma; Thrombocytopenia; Time Factors	1995
Busulfan-containing pre-transplant regimens for the treatment of solid tumors. Bone marrow transplantation, 1994, Volume: 14, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Busulfan; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasms; Ovarian Neoplasms; Pilot Projects; Retrospective Studies; Sarcoma	1994
Mutation rates and mechanisms of resistance to etoposide determined from fluctuation analysis. Journal of the National Cancer Institute, 1994, 08-03, Volume: 86, Issue:15 Topics: DNA, Complementary; Drug Resistance; Etoposide; Female; Humans; Models, Statistical; Mutation; Polymerase Chain Reaction; Probability; RNA, Neoplasm; Sarcoma; Tumor Cells, Cultured; Uterine Neoplasms	1994
17 beta-estradiol glucuronide: an inducer of cholestasis and a physiological substrate for the multidrug resistance transporter. Cancer research, 1993, Nov-15, Volume: 53, Issue:22 Topics: Cholestasis; Doxorubicin; Drug Resistance; Estradiol; Estriol; Etoposide; Humans; Leukemia, Myeloid; Paclitaxel; Sarcoma; Tumor Cells, Cultured; Vinblastine	1993
21-day schedule oral etoposide in children--a feasibility study. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:16 Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Leukemia; Leukopenia; Male; Neuroblastoma; Neutropenia; Sarcoma; Thrombocytopenia; Treatment Outcome	1993
Ifosfamide-induced hyperpigmentation. Cancer, 1994, Jan-01, Volume: 73, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Etoposide; Female; Humans; Hyperpigmentation; Ifosfamide; Infant; Male; Sarcoma; Time Factors	1994
High-dose VP16 cisplatinum in soft tissue sarcoma of children. Cancer chemotherapy and pharmacology, 1994, Volume: 33, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Male; Sarcoma; Treatment Outcome	1994
[Intensive chemotherapy for alveolar soft part sarcoma with lung metastasis in a child]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Sarcoma; Soft Tissue Neoplasms; Vincristine	1993
24-hour plasma etoposide profile after oral and intravenous administration in children. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:10 Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Etoposide; Humans; Injections, Intravenous; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma; Soft Tissue Neoplasms; Time Factors	1993
Etoposide pharmacokinetics in children: the development and prospective validation of a dosing equation. Cancer research, 1993, Oct-15, Volume: 53, Issue:20 Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Male; Metabolic Clearance Rate; Neoplasms; Neuroblastoma; Pineal Gland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma; Soft Tissue Neoplasms; Teratoma	1993
Ifosfamide combination regimens for soft-tissue sarcoma. Cancer chemotherapy and pharmacology, 1993, Volume: 31 Suppl 2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Mesna; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Urologic Diseases	1993
Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen. Cancer chemotherapy and pharmacology, 1993, Volume: 31 Suppl 2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Male; Mesna; Middle Aged; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Urologic Diseases	1993
Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: a pilot study. Cancer chemotherapy and pharmacology, 1993, Volume: 31 Suppl 2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Feasibility Studies; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Pilot Projects; Sarcoma; Treatment Outcome	1993
Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine. Cancer chemotherapy and pharmacology, 1996, Volume: 37, Issue:6 Topics: Antineoplastic Agents; Doxorubicin; Drug Resistance, Multiple; Etoposide; Guanidines; Humans; Paclitaxel; Polymers; Sarcoma; Spermine; Tumor Cells, Cultured; Vinblastine	1996
Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study. Seminars in oncology, 1996, Volume: 23, Issue:3 Suppl 6 Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Etoposide; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukopenia; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Pilot Projects; Remission Induction; Sarcoma; Thrombocytopenia	1996
Etoposide for soft tissue sarcomas: fact or fiction. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:10 Topics: Antineoplastic Agents, Phytogenic; Etoposide; Humans; Sarcoma; Soft Tissue Neoplasms	1997
Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial. Medical and pediatric oncology, 1998, Volume: 30, Issue:5 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Germany; Humans; Hyperthermia, Induced; Ifosfamide; Male; Neuroectodermal Tumors; Prospective Studies; Recurrence; Rhabdomyosarcoma; Sarcoma; Survival Analysis; Treatment Outcome	1998
In vitro evaluation of synergism or antagonism with combinations of new cytotoxic agents. Anti-cancer drugs, 1998, Volume: 9, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Gemcitabine; Humans; Male; Paclitaxel; Prostatic Neoplasms; Sarcoma; Tumor Cells, Cultured; Vinblastine; Vinorelbine	1998
Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide. European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Feasibility Studies; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Infant, Newborn; Meningeal Neoplasms; Pilot Projects; Rhabdomyosarcoma; Risk Factors; Sarcoma; Urogenital Neoplasms; Vincristine	1998
Treatment of soft-tissue sarcomas: high-dose ifosfamide or combination of ifosfamide and etoposide? Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:1 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome	1999
Role of the combination of ifosfamide and etoposide in the treatment of soft tissue sarcomas. Oncology, 1999, Volume: 57, Issue:2 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ifosfamide; Sarcoma	1999
Granulocyte colony stimulating factor permits dose intensification by interval compression in the treatment of Ewing's sarcomas and soft tissue sarcomas in children. European journal of cancer (Oxford, England : 1990), 2000, Volume: 36, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Male; Pilot Projects; Prospective Studies; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Survival Analysis; Vincristine	2000
Nephrotoxicity of ifosfamide, carboplatin and etoposide (ICE) alone or combined with extracorporeal or radiant-heat-induced whole-body hyperthermia. Journal of cancer research and clinical oncology, 2000, Volume: 126, Issue:3 Topics: Adolescent; Adult; Aged; Albuminuria; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase II as Topic; Creatinine; Etoposide; Female; Glomerular Filtration Rate; Glycoproteins; Humans; Hyperthermia, Induced; Ifosfamide; Immunoglobulin G; Kidney; Male; Membrane Glycoproteins; Middle Aged; Sarcoma; Trypsin Inhibitor, Kunitz Soybean	2000
Assessment of systemic toxicity in children receiving chemotherapy with cyclosporine for sarcoma. Medical and pediatric oncology, 2000, Volume: 34, Issue:4 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Transfusion; Chi-Square Distribution; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Dactinomycin; Etoposide; Female; Fever; Humans; Ifosfamide; Male; Neutropenia; Pilot Projects; Platelet Transfusion; Retrospective Studies; Sarcoma; Sepsis; Treatment Outcome; Vincristine	2000
MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells. British journal of cancer, 2000, Volume: 83, Issue:7 Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclosporins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Multidrug Resistance-Associated Proteins; Mutation; Neoplasm Proteins; Paclitaxel; Phenotype; Rhodamine 123; RNA, Messenger; Sarcoma; Tritium; Tumor Cells, Cultured; Uterine Neoplasms; Vault Ribonucleoprotein Particles; Vinblastine	2000
[Bronchiolitis obliterans with organizing pneumonia secondary to chemotherapy in a child with primary pericardial sarcoma]. Revista medica de Chile, 2000, Volume: 128, Issue:6 Topics: Antineoplastic Agents; Biopsy; Child, Preschool; Cryptogenic Organizing Pneumonia; Cyclophosphamide; Doxorubicin; Etoposide; Heart Neoplasms; Humans; Male; Pericardium; Prednisolone; Sarcoma; Tomography, X-Ray Computed; Vincristine	2000
Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: identification of ecteinascidin-743 as a potent cytotoxic agent. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:9 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Cycle; Cell Survival; Dioxoles; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Humans; Inhibitory Concentration 50; Isoquinolines; Methotrexate; Proto-Oncogene Proteins c-bcl-2; Retinoblastoma Protein; Sarcoma; Sensitivity and Specificity; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2001
[Pilot phase II trial of high-dose etoposide combined with cisplatin in the treatment of refractory lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Sarcoma	1992
Oral etoposide in treatment of advanced refractory sarcomas. Journal of the National Cancer Institute, 1992, Dec-02, Volume: 84, Issue:23 Topics: Administration, Oral; Etoposide; Humans; Sarcoma	1992
High dose chemotherapy with ABMT in soft tissue sarcomas: a report of 22 cases. Bone marrow transplantation, 1992, Volume: 10, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Gastrointestinal Diseases; Humans; Ifosfamide; Male; Melphalan; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Vincristine; Whole-Body Irradiation	1992
Pilot study of a rapid etoposide-cisplatin regimen in paediatric soft tissue sarcomas. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28, Issue:2-3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Infant; Male; Pilot Projects; Sarcoma; Soft Tissue Neoplasms	1992
Poor prognosis of mediastinal germ cell cancers containing sarcomatous components. Cancer, 1990, Sep-15, Volume: 66, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Etoposide; Humans; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Prognosis; Sarcoma; Survival Rate; Vincristine	1990
Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: updated report on 65 patients. Journal of cancer research and clinical oncology, 1991, Volume: 117 Suppl 4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Remission Induction; Sarcoma	1991
Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Drug Evaluation; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Mesna; Middle Aged; Regression Analysis; Sarcoma; Soft Tissue Neoplasms	1990
Differential protective effects of varying degrees of hypoxia on the cytotoxicities of etoposide and bleomycin. Cancer chemotherapy and pharmacology, 1987, Volume: 19, Issue:4 Topics: Bleomycin; Cell Line; Cell Survival; Doxorubicin; Drug Resistance; Etoposide; Humans; Mitomycin; Mitomycins; Mitotic Index; Oxygen; Sarcoma	1987
Phase II study of ifosfamide-etoposide-mesna in adults with advanced nonosseous sarcomas. Journal of the National Cancer Institute, 1989, Jun-07, Volume: 81, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Male; Mesna; Middle Aged; Remission Induction; Sarcoma	1989
Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro. Experimental hematology, 1985, Volume: 13 Suppl 16 Topics: Antineoplastic Agents; Bleomycin; Breast Neoplasms; Cell Survival; Cells, Cultured; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Hematopoietic Stem Cells; Humans; Lung Neoplasms; Melanoma; Neoplastic Stem Cells; Sarcoma; Stem Cells	1985
Reversal by cefoperazone of resistance to etoposide, doxorubicin, and vinblastine in multidrug resistant human sarcoma cells. Cancer research, 1989, Dec-15, Volume: 49, Issue:24 Pt 1 Topics: Cefoperazone; Cell Survival; Chemical Phenomena; Chemistry; Doxorubicin; Drug Resistance; Etoposide; Humans; Sarcoma; Tumor Cells, Cultured; Vinblastine	1989
Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Child; Combined Modality Therapy; Cystitis; Drug Evaluation; Etoposide; Humans; Ifosfamide; Mesna; Neoplasm Recurrence, Local; Sarcoma	1987
Phase II trial of cisplatin and etoposide in children with advanced soft tissue sarcoma: a report from the Italian Cooperative Rhabdomyosarcoma Group. Cancer treatment reports, 1987, Volume: 71, Issue:5 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Drug Evaluation; Etoposide; Humans; Rhabdomyosarcoma; Sarcoma; Soft Tissue Neoplasms	1987
VP-16 in advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma group. European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:5 Topics: Adolescent; Adult; Aged; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms	1987
Inefficacy of cisplatin and etoposide as salvage therapy for children with recurrent or unresponsive soft tissue sarcoma. Cancer treatment reports, 1987, Volume: 71, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Etoposide; Humans; Infant; Neoplasm Recurrence, Local; Sarcoma	1987